Human Gene MAPK14 (ENST00000229795.8) from GENCODE V44
  Description: Homo sapiens mitogen-activated protein kinase 14 (MAPK14), transcript variant 1, mRNA. (from RefSeq NM_001315)
RefSeq Summary (NM_001315): The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008].
Gencode Transcript: ENST00000229795.8
Gencode Gene: ENSG00000112062.12
Transcript (Including UTRs)
   Position: hg38 chr6:36,027,808-36,111,236 Size: 83,429 Total Exon Count: 12 Strand: +
Coding Region
   Position: hg38 chr6:36,028,158-36,108,447 Size: 80,290 Coding Exon Count: 12 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr6:36,027,808-36,111,236)mRNA (may differ from genome)Protein (360 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGeneCardsHGNC
HPRDMalacardsMGIneXtProtOMIMPubMed
ReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: MK14_HUMAN
DESCRIPTION: RecName: Full=Mitogen-activated protein kinase 14; Short=MAP kinase 14; Short=MAPK 14; EC=2.7.11.24; AltName: Full=Cytokine suppressive anti-inflammatory drug-binding protein; Short=CSAID-binding protein; Short=CSBP; AltName: Full=MAP kinase MXI2; AltName: Full=MAX-interacting protein 2; AltName: Full=Mitogen-activated protein kinase p38 alpha; Short=MAP kinase p38 alpha; AltName: Full=Stress-activated protein kinase 2a; Short=SAPK2a;
FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF- induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14- mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF- kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression. Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis. Phosphorylates S100A9 at 'Thr-113'.
CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
COFACTOR: Magnesium.
ENZYME REGULATION: Activated by cell stresses such as DNA damage, heat shock, osmotic shock, anisomycin and sodium arsenite, as well as pro-inflammatory stimuli such as bacterial lipopolysaccharide (LPS) and interleukin-1. Activation occurs through dual phosphorylation of Thr-180 and Tyr-182 by either of two dual specificity kinases, MAP2K3/MKK3 or MAP2K6/MKK6, and potentially also MAP2K4/MKK4, as well as by TAB1-mediated autophosphorylation. MAPK14 phosphorylated on both Thr-180 and Tyr-182 is 10-20-fold more active than MAPK14 phosphorylated only on Thr-180, whereas MAPK14 phosphorylated on Tyr-182 alone is inactive. whereas Thr- 180 is necessary for catalysis, Tyr-182 may be required for auto- activation and substrate recognition. Phosphorylated at Tyr-323 by ZAP70 in an alternative activation pathway in response to TCR signaling in T-cells. This alternative pathway is inhibited by GADD45A. Inhibited by dual specificity phosphatases, such as DUSP1, DUSP10, and DUSP16. Specifically inhibited by the binding of pyridinyl-imidazole compounds, which are cytokine-suppressive anti-inflammatory drugs (CSAID). Isoform Mxi2 is 100-fold less sensitive to these agents than the other isoforms and is not inhibited by DUSP1. Isoform Exip is not activated by MAP2K6. SB203580 is an inhibitor of MAPK14.
SUBUNIT: Binds to a kinase interaction motif within the protein tyrosine phosphatase, PTPRR (By similarity). This interaction retains MAPK14 in the cytoplasm and prevents nuclear accumulation (By similarity). Interacts with SPAG9 and GADD45A (By similarity). Interacts with CDC25B, CDC25C, DUSP1, DUSP10, DUSP16, NP60, FAM48A and TAB1. Interacts with casein kinase II subunits CSNK2A1 and CSNK2B.
INTERACTION: Q8NEM7:FAM48A; NbExp=5; IntAct=EBI-73946, EBI-946984; P49137:MAPKAPK2; NbExp=2; IntAct=EBI-73946, EBI-993299; P06400:RB1; NbExp=3; IntAct=EBI-73946, EBI-491274; O75676:RPS6KA4; NbExp=2; IntAct=EBI-73946, EBI-73933; Q92574:TSC1; NbExp=2; IntAct=EBI-73946, EBI-1047085; Q07352:ZFP36L1; NbExp=2; IntAct=EBI-73946, EBI-721823;
SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
TISSUE SPECIFICITY: Brain, heart, placenta, pancreas and skeletal muscle. Expressed to a lesser extent in lung, liver and kidney.
DOMAIN: The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.
PTM: Dually phosphorylated on Thr-180 and Tyr-182 by the MAP2Ks MAP2K3/MKK3, MAP2K4/MKK4 and MAP2K6/MKK6 in response to inflammatory citokines, environmental stress or growth factors, which a ctivates the enzyme. Dual phosphorylation can also be mediated by TAB1-mediated autophosphorylation. TCR engagement in T-cells also leads to Tyr-323 phosphorylation by ZAP70. Dephosphorylated and inactivated by DUPS1, DUSP10 and DUSP16.
PTM: Acetylated at Lys-53 and Lys-152 by KAT2B and EP300. Acetylation at Lys-53 increases the affinity for ATP and enhances kinase activity. Lys-53 and Lys-152 are deacetylated by HDAC3.
PTM: Ubiquitinated. Ubiquitination leads to degradation by the proteasome pathway.
SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.
SIMILARITY: Contains 1 protein kinase domain.
WEB RESOURCE: Name=Wikipedia; Note=P38 mitogen-activated protein kinases entry; URL="http://en.wikipedia.org/wiki/P38_mitogen-activated_protein_kinases";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: MAPK14
Diseases sorted by gene-association score: tuberculosis (5), atherosclerosis (4), patellar tendinitis (4), chlamydia (4), gastric adenocarcinoma (3), lumbosacral lipoma (3), hepatocellular carcinoma (2), doxorubicin induced cardiomyopathy (2), breast cancer (2), chorioangioma (1), agraphia (1), hemangioma of intra-abdominal structure (1), carbuncle (1), amphetamine abuse (1)

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 38.91 RPKM in Whole Blood
Total median expression: 596.91 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -203.70350-0.582 Picture PostScript Text
3' UTR -816.502789-0.293 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR011009 - Kinase-like_dom
IPR003527 - MAP_kinase_CS
IPR008352 - MAPK_p38
IPR000719 - Prot_kinase_cat_dom
IPR017441 - Protein_kinase_ATP_BS
IPR002290 - Ser/Thr_dual-sp_kinase_dom

Pfam Domains:
PF00069 - Protein kinase domain

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1A9U - X-ray MuPIT 1BL6 - X-ray MuPIT 1BL7 - X-ray MuPIT 1BMK - X-ray MuPIT 1DI9 - X-ray MuPIT 1IAN - X-ray MuPIT 1KV1 - X-ray MuPIT 1KV2 - X-ray MuPIT 1M7Q - X-ray MuPIT 1OUK - X-ray MuPIT 1OUY - X-ray MuPIT 1OVE - X-ray MuPIT 1OZ1 - X-ray MuPIT 1R39 - X-ray MuPIT 1R3C - X-ray MuPIT 1W7H - X-ray MuPIT 1W82 - X-ray MuPIT 1W83 - X-ray MuPIT 1W84 - X-ray MuPIT 1WBN - X-ray MuPIT 1WBO - X-ray MuPIT 1WBS - X-ray MuPIT 1WBT - X-ray MuPIT 1WBV - X-ray MuPIT 1WBW - X-ray MuPIT 1WFC - X-ray MuPIT 1YQJ - X-ray MuPIT 1ZYJ - X-ray MuPIT 1ZZ2 - X-ray MuPIT 1ZZL - X-ray MuPIT 2BAJ - X-ray MuPIT 2BAK - X-ray MuPIT 2BAL - X-ray MuPIT 2BAQ - X-ray MuPIT 2FSL - X-ray MuPIT 2FSM - X-ray MuPIT 2FSO - X-ray MuPIT 2FST - X-ray MuPIT 2GFS - X-ray MuPIT 2I0H - X-ray MuPIT 2LGC - NMR MuPIT 2NPQ - X-ray MuPIT 2OKR - X-ray MuPIT 2ONL - X-ray MuPIT 2QD9 - X-ray MuPIT 2RG5 - X-ray MuPIT 2RG6 - X-ray MuPIT 2Y8O - X-ray MuPIT 2YIS - X-ray MuPIT 2YIW - X-ray MuPIT 2YIX - X-ray MuPIT 2ZAZ - X-ray MuPIT 2ZB0 - X-ray MuPIT 2ZB1 - X-ray MuPIT 3BV2 - X-ray MuPIT 3BV3 - X-ray MuPIT 3BX5 - X-ray MuPIT 3C5U - X-ray MuPIT 3CTQ - X-ray MuPIT 3D7Z - X-ray MuPIT 3D83 - X-ray MuPIT 3DS6 - X-ray MuPIT 3DT1 - X-ray MuPIT 3E92 - X-ray MuPIT 3E93 - X-ray MuPIT 3FC1 - X-ray MuPIT 3FI4 - X-ray MuPIT 3FKL - X-ray MuPIT 3FKN - X-ray MuPIT 3FKO - X-ray MuPIT 3FL4 - X-ray MuPIT 3FLN - X-ray MuPIT 3FLQ - X-ray MuPIT 3FLS - X-ray MuPIT 3FLW - X-ray MuPIT 3FLY - X-ray MuPIT 3FLZ - X-ray MuPIT 3FMH - X-ray MuPIT 3FMJ - X-ray MuPIT 3FMK - X-ray MuPIT 3FML - X-ray MuPIT 3FMM - X-ray MuPIT 3FMN - X-ray MuPIT 3FSF - X-ray MuPIT 3FSK - X-ray MuPIT 3GC7 - X-ray MuPIT 3GCP - X-ray MuPIT 3GCQ - X-ray MuPIT 3GCS - X-ray MuPIT 3GCU - X-ray MuPIT 3GCV - X-ray MuPIT 3GFE - X-ray MuPIT 3GI3 - X-ray MuPIT 3HA8 - X-ray MuPIT 3HEC - X-ray MuPIT 3HEG - X-ray MuPIT 3HL7 - X-ray MuPIT 3HLL - X-ray MuPIT 3HP2 - X-ray MuPIT 3HP5 - X-ray MuPIT 3HRB - X-ray MuPIT 3HUB - X-ray MuPIT 3HUC - X-ray MuPIT 3HV3 - X-ray MuPIT 3HV4 - X-ray MuPIT 3HV5 - X-ray MuPIT 3HV6 - X-ray MuPIT 3HV7 - X-ray MuPIT 3HVC - X-ray MuPIT 3IPH - X-ray MuPIT 3ITZ - X-ray MuPIT 3IW5 - X-ray MuPIT 3IW6 - X-ray MuPIT 3IW7 - X-ray MuPIT 3IW8 - X-ray MuPIT 3K3I - X-ray MuPIT 3K3J - X-ray MuPIT 3KF7 - X-ray MuPIT 3KQ7 - X-ray MuPIT 3L8S - X-ray MuPIT 3L8X - X-ray MuPIT 3LFA - X-ray MuPIT 3LFB - X-ray MuPIT 3LFC - X-ray MuPIT 3LFD - X-ray MuPIT 3LFE - X-ray MuPIT 3LFF - X-ray MuPIT 3LHJ - X-ray MuPIT 3MGY - X-ray MuPIT 3MH0 - X-ray MuPIT 3MH1 - X-ray MuPIT 3MH2 - X-ray MuPIT 3MH3 - X-ray MuPIT 3MPA - X-ray MuPIT 3MPT - X-ray MuPIT 3MVL - X-ray MuPIT 3MVM - X-ray MuPIT 3MW1 - X-ray MuPIT 3NEW - X-ray MuPIT 3NNU - X-ray MuPIT 3NNV - X-ray MuPIT 3NNW - X-ray MuPIT 3NNX - X-ray MuPIT 3NWW - X-ray MuPIT 3O8P - X-ray MuPIT 3O8T - X-ray MuPIT 3O8U - X-ray MuPIT 3OBG - X-ray MuPIT 3OBJ - X-ray MuPIT 3OC1 - X-ray MuPIT 3OCG - X-ray MuPIT 3OD6 - X-ray MuPIT 3ODY - X-ray MuPIT 3ODZ - X-ray MuPIT 3OEF - X-ray MuPIT 3PG3 - X-ray MuPIT 3QUD - X-ray MuPIT 3QUE - X-ray MuPIT 3RIN - X-ray MuPIT 3ROC - X-ray MuPIT 3S3I - X-ray MuPIT 3S4Q - X-ray MuPIT 3U8W - X-ray MuPIT 3ZS5 - X-ray MuPIT 3ZSG - X-ray MuPIT 3ZSH - X-ray MuPIT 3ZSI - X-ray MuPIT 3ZYA - X-ray MuPIT 4A9Y - X-ray MuPIT 4AA0 - X-ray MuPIT 4AA4 - X-ray MuPIT 4AA5 - X-ray MuPIT 4AAC - X-ray MuPIT 4EWQ - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on Q16539
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserGenome BrowserNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGDEnsembl   
Protein SequenceProtein SequenceProtein Sequence   
AlignmentAlignmentAlignment   

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0004672 protein kinase activity
GO:0004674 protein serine/threonine kinase activity
GO:0004707 MAP kinase activity
GO:0004708 MAP kinase kinase activity
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0016301 kinase activity
GO:0016740 transferase activity
GO:0019899 enzyme binding
GO:0019903 protein phosphatase binding
GO:0048273 mitogen-activated protein kinase p38 binding
GO:0051525 NFAT protein binding

Biological Process:
GO:0000077 DNA damage checkpoint
GO:0000187 activation of MAPK activity
GO:0000902 cell morphogenesis
GO:0001502 cartilage condensation
GO:0001525 angiogenesis
GO:0001890 placenta development
GO:0002062 chondrocyte differentiation
GO:0002741 positive regulation of cytokine secretion involved in immune response
GO:0006006 glucose metabolic process
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0006357 regulation of transcription from RNA polymerase II promoter
GO:0006468 protein phosphorylation
GO:0006915 apoptotic process
GO:0006935 chemotaxis
GO:0006974 cellular response to DNA damage stimulus
GO:0007165 signal transduction
GO:0007166 cell surface receptor signaling pathway
GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway
GO:0007519 skeletal muscle tissue development
GO:0010628 positive regulation of gene expression
GO:0010759 positive regulation of macrophage chemotaxis
GO:0010831 positive regulation of myotube differentiation
GO:0014835 myoblast differentiation involved in skeletal muscle regeneration
GO:0016310 phosphorylation
GO:0018105 peptidyl-serine phosphorylation
GO:0019395 fatty acid oxidation
GO:0030278 regulation of ossification
GO:0030316 osteoclast differentiation
GO:0031281 positive regulation of cyclase activity
GO:0031663 lipopolysaccharide-mediated signaling pathway
GO:0032495 response to muramyl dipeptide
GO:0032496 response to lipopolysaccharide
GO:0035556 intracellular signal transduction
GO:0035924 cellular response to vascular endothelial growth factor stimulus
GO:0035994 response to muscle stretch
GO:0038066 p38MAPK cascade
GO:0042307 positive regulation of protein import into nucleus
GO:0042770 signal transduction in response to DNA damage
GO:0043312 neutrophil degranulation
GO:0045648 positive regulation of erythrocyte differentiation
GO:0045663 positive regulation of myoblast differentiation
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0046326 positive regulation of glucose import
GO:0048010 vascular endothelial growth factor receptor signaling pathway
GO:0051146 striated muscle cell differentiation
GO:0051149 positive regulation of muscle cell differentiation
GO:0060045 positive regulation of cardiac muscle cell proliferation
GO:0070935 3'-UTR-mediated mRNA stabilization
GO:0071222 cellular response to lipopolysaccharide
GO:0071223 cellular response to lipoteichoic acid
GO:0071356 cellular response to tumor necrosis factor
GO:0071479 cellular response to ionizing radiation
GO:0090090 negative regulation of canonical Wnt signaling pathway
GO:0090336 positive regulation of brown fat cell differentiation
GO:0090400 stress-induced premature senescence
GO:0098586 cellular response to virus
GO:1900015 regulation of cytokine production involved in inflammatory response
GO:1901741 positive regulation of myoblast fusion
GO:1901796 regulation of signal transduction by p53 class mediator
GO:1905050 positive regulation of metallopeptidase activity
GO:2000379 positive regulation of reactive oxygen species metabolic process
GO:2001184 positive regulation of interleukin-12 secretion
GO:0043536 positive regulation of blood vessel endothelial cell migration

Cellular Component:
GO:0000922 spindle pole
GO:0005576 extracellular region
GO:0005623 cell
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005739 mitochondrion
GO:0005829 cytosol
GO:0016607 nuclear speck
GO:0034774 secretory granule lumen
GO:1904813 ficolin-1-rich granule lumen


-  Descriptions from all associated GenBank mRNAs
  HW061150 - JP 2012529430-A/25: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
JA482104 - Sequence 87 from Patent WO2011072091.
JB251958 - Sequence 25 from Patent EP2440214.
JE980396 - Sequence 87 from Patent EP2862929.
LP764857 - Sequence 25 from Patent EP3276004.
HW061147 - JP 2012529430-A/22: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
HW061148 - JP 2012529430-A/23: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
HW061149 - JP 2012529430-A/24: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
JA482102 - Sequence 85 from Patent WO2011072091.
JA482103 - Sequence 86 from Patent WO2011072091.
JA482105 - Sequence 88 from Patent WO2011072091.
JB251955 - Sequence 22 from Patent EP2440214.
JB251956 - Sequence 23 from Patent EP2440214.
JB251957 - Sequence 24 from Patent EP2440214.
JE980394 - Sequence 85 from Patent EP2862929.
JE980395 - Sequence 86 from Patent EP2862929.
JE980397 - Sequence 88 from Patent EP2862929.
LF385176 - JP 2014500723-A/192679: Polycomb-Associated Non-Coding RNAs.
LP764854 - Sequence 22 from Patent EP3276004.
LP764855 - Sequence 23 from Patent EP3276004.
LP764856 - Sequence 24 from Patent EP3276004.
MA620753 - JP 2018138019-A/192679: Polycomb-Associated Non-Coding RNAs.
AK291709 - Homo sapiens cDNA FLJ76665 complete cds, highly similar to Homo sapiens mitogen-activated protein kinase 14 (MAPK14), transcript variant 2, mRNA.
HH837096 - Sequence 23 from Patent EP2231168.
HI214737 - Sequence 23 from Patent EP2076526.
HV601539 - JP 2011500003-A/23: Novel siRNA Structures.
HV856612 - JP 2010507387-A/23: Novel siRNAs and Methods of Use Thereof.
HW165099 - JP 2013102767-A/23: Novel siRNA's and Use Thereof.
HW675607 - JP 2014210789-A/23: Novel siRNA Structures.
HW835295 - JP 2015051004-A/23: Novel siRNA's and Use Thereof.
JA538138 - Sequence 23 from Patent EP2371958.
HH837093 - Sequence 20 from Patent EP2231168.
HH837094 - Sequence 21 from Patent EP2231168.
HH837095 - Sequence 22 from Patent EP2231168.
HI214734 - Sequence 20 from Patent EP2076526.
HI214735 - Sequence 21 from Patent EP2076526.
HI214736 - Sequence 22 from Patent EP2076526.
HV601536 - JP 2011500003-A/20: Novel siRNA Structures.
HV601537 - JP 2011500003-A/21: Novel siRNA Structures.
HV601538 - JP 2011500003-A/22: Novel siRNA Structures.
HV856609 - JP 2010507387-A/20: Novel siRNAs and Methods of Use Thereof.
HV856610 - JP 2010507387-A/21: Novel siRNAs and Methods of Use Thereof.
HV856611 - JP 2010507387-A/22: Novel siRNAs and Methods of Use Thereof.
HW165096 - JP 2013102767-A/20: Novel siRNA's and Use Thereof.
HW165097 - JP 2013102767-A/21: Novel siRNA's and Use Thereof.
HW165098 - JP 2013102767-A/22: Novel siRNA's and Use Thereof.
HW675604 - JP 2014210789-A/20: Novel siRNA Structures.
HW675605 - JP 2014210789-A/21: Novel siRNA Structures.
HW675606 - JP 2014210789-A/22: Novel siRNA Structures.
HW835292 - JP 2015051004-A/20: Novel siRNA's and Use Thereof.
HW835293 - JP 2015051004-A/21: Novel siRNA's and Use Thereof.
HW835294 - JP 2015051004-A/22: Novel siRNA's and Use Thereof.
JA538135 - Sequence 20 from Patent EP2371958.
JA538136 - Sequence 21 from Patent EP2371958.
JA538137 - Sequence 22 from Patent EP2371958.
L35263 - Human CSaids binding protein (CSBP1) mRNA, complete cds.
LP895545 - Sequence 409 from Patent EP3253886.
AK303414 - Homo sapiens cDNA FLJ58214 complete cds, highly similar to Mitogen-activated protein kinase 14 (EC2.7.11.24).
BC000092 - Homo sapiens mitogen-activated protein kinase 14, mRNA (cDNA clone MGC:2183 IMAGE:3505234), complete cds.
BC031574 - Homo sapiens mitogen-activated protein kinase 14, mRNA (cDNA clone MGC:34610 IMAGE:5181064), complete cds.
L35264 - Human CSaids binding protein (CSBP2) mRNA, complete cds.
U19775 - Human MAP kinase Mxi2 (MXI2) mRNA, complete cds.
L35253 - Human p38 mitogen activated protein (MAP) kinase mRNA, complete cds.
AF100544 - Homo sapiens stress-activated protein kinase 2a (CSBP) mRNA, complete cds.
FJ032367 - Homo sapiens mitogen-activated protein kinase 14 isoform 4 (MAPK14) mRNA, complete cds.
FJ032368 - Homo sapiens mitogen-activated protein kinase 14 isoform 5 (MAPK14) mRNA, complete cds.
AB384830 - Synthetic construct DNA, clone: pF1KB3657, Homo sapiens MAPK14 gene for mitogen-activated protein kinase 14, complete cds, without stop codon, in Flexi system.
BT006933 - Homo sapiens mitogen-activated protein kinase 14 mRNA, complete cds.
KJ890977 - Synthetic construct Homo sapiens clone ccsbBroadEn_00371 MAPK14 gene, encodes complete protein.
KJ905182 - Synthetic construct Homo sapiens clone ccsbBroadEn_14596 MAPK14 gene, encodes complete protein.
CR536505 - Homo sapiens full open reading frame cDNA clone RZPDo834D0720D for gene MAPK14, mitogen-activated protein kinase 14; complete cds, incl. stopcodon.
AB074150 - Homo sapiens Exip mRNA for Alternative spliced variant of p38alpha EXIP, complete cds.
JD217393 - Sequence 198417 from Patent EP1572962.
LF340911 - JP 2014500723-A/148414: Polycomb-Associated Non-Coding RNAs.
MA576488 - JP 2018138019-A/148414: Polycomb-Associated Non-Coding RNAs.
JD336527 - Sequence 317551 from Patent EP1572962.
JD538172 - Sequence 519196 from Patent EP1572962.
JD216918 - Sequence 197942 from Patent EP1572962.
JD098618 - Sequence 79642 from Patent EP1572962.
JD140878 - Sequence 121902 from Patent EP1572962.
LF340912 - JP 2014500723-A/148415: Polycomb-Associated Non-Coding RNAs.
MA576489 - JP 2018138019-A/148415: Polycomb-Associated Non-Coding RNAs.
LF340921 - JP 2014500723-A/148424: Polycomb-Associated Non-Coding RNAs.
MA576498 - JP 2018138019-A/148424: Polycomb-Associated Non-Coding RNAs.
LF340922 - JP 2014500723-A/148425: Polycomb-Associated Non-Coding RNAs.
MA576499 - JP 2018138019-A/148425: Polycomb-Associated Non-Coding RNAs.
LF340928 - JP 2014500723-A/148431: Polycomb-Associated Non-Coding RNAs.
MA576505 - JP 2018138019-A/148431: Polycomb-Associated Non-Coding RNAs.
LF340929 - JP 2014500723-A/148432: Polycomb-Associated Non-Coding RNAs.
MA576506 - JP 2018138019-A/148432: Polycomb-Associated Non-Coding RNAs.
Z25432 - H.sapiens protein-serine/threonine kinase gene, complete CDS.
LF340931 - JP 2014500723-A/148434: Polycomb-Associated Non-Coding RNAs.
MA576508 - JP 2018138019-A/148434: Polycomb-Associated Non-Coding RNAs.
LF340932 - JP 2014500723-A/148435: Polycomb-Associated Non-Coding RNAs.
MA576509 - JP 2018138019-A/148435: Polycomb-Associated Non-Coding RNAs.
LF340937 - JP 2014500723-A/148440: Polycomb-Associated Non-Coding RNAs.
MA576514 - JP 2018138019-A/148440: Polycomb-Associated Non-Coding RNAs.
DQ573654 - Homo sapiens piRNA piR-41766, complete sequence.
JD279796 - Sequence 260820 from Patent EP1572962.
JD550045 - Sequence 531069 from Patent EP1572962.
JD549109 - Sequence 530133 from Patent EP1572962.
JD354584 - Sequence 335608 from Patent EP1572962.
JD108585 - Sequence 89609 from Patent EP1572962.
JD187276 - Sequence 168300 from Patent EP1572962.
JD260284 - Sequence 241308 from Patent EP1572962.
JD354899 - Sequence 335923 from Patent EP1572962.
JD323528 - Sequence 304552 from Patent EP1572962.
JD428793 - Sequence 409817 from Patent EP1572962.
JD328607 - Sequence 309631 from Patent EP1572962.
JD302065 - Sequence 283089 from Patent EP1572962.
JD043363 - Sequence 24387 from Patent EP1572962.
JD226040 - Sequence 207064 from Patent EP1572962.
JD456351 - Sequence 437375 from Patent EP1572962.
JD489717 - Sequence 470741 from Patent EP1572962.
JD280494 - Sequence 261518 from Patent EP1572962.
JD201890 - Sequence 182914 from Patent EP1572962.
JD279289 - Sequence 260313 from Patent EP1572962.
JD436215 - Sequence 417239 from Patent EP1572962.
JD355394 - Sequence 336418 from Patent EP1572962.
JD299976 - Sequence 281000 from Patent EP1572962.
LF340938 - JP 2014500723-A/148441: Polycomb-Associated Non-Coding RNAs.
MA576515 - JP 2018138019-A/148441: Polycomb-Associated Non-Coding RNAs.
JD175048 - Sequence 156072 from Patent EP1572962.
JD566054 - Sequence 547078 from Patent EP1572962.
JD295510 - Sequence 276534 from Patent EP1572962.
LF340939 - JP 2014500723-A/148442: Polycomb-Associated Non-Coding RNAs.
MA576516 - JP 2018138019-A/148442: Polycomb-Associated Non-Coding RNAs.
JC276891 - Sequence 16 from Patent WO2013072465.
JD346304 - Sequence 327328 from Patent EP1572962.
JD390826 - Sequence 371850 from Patent EP1572962.
JD308742 - Sequence 289766 from Patent EP1572962.
JD095939 - Sequence 76963 from Patent EP1572962.
JC276894 - Sequence 19 from Patent WO2013072465.
JD525911 - Sequence 506935 from Patent EP1572962.
JD359089 - Sequence 340113 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_SARSpathway - SARS Coronavirus Protease
h_biopeptidesPathway - Bioactive Peptide Induced Signaling Pathway
h_dspPathway - Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases
h_fMLPpathway - fMLP induced chemokine gene expression in HMC-1 cells
h_keratinocytePathway - Keratinocyte Differentiation
h_nfatPathway - NFAT and Hypertrophy of the heart (Transcription in the broken heart)
h_tollPathway - Toll-Like Receptor Pathway
h_Ccr5Pathway - Pertussis toxin-insensitive CCR5 Signaling in Macrophage
h_GATA3pathway - GATA3 participate in activating the Th2 cytokine genes expression
h_crebPathway - Transcription factor CREB and its extracellular signals
h_egfr_smrtePathway - Map Kinase Inactivation of SMRT Corepressor
h_nthiPathway - NFkB activation by Nontypeable Hemophilus influenzae
h_IL12Pathway - IL12 and Stat4 Dependent Signaling Pathway in Th1 Development
h_tall1Pathway - TACI and BCMA stimulation of B cell immune responses.
h_bcrPathway - BCR Signaling Pathway
h_il1rPathway - Signal transduction through IL1R
h_p38mapkPathway - p38 MAPK Signaling Pathway
h_eif4Pathway - Regulation of eIF4e and p70 S6 Kinase
h_arenrf2Pathway - Oxidative Stress Induced Gene Expression Via Nrf2
h_hdacPathway - Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK)
h_41bbPathway - The 4-1BB-dependent immune response
h_tsp1Pathway - TSP-1 Induced Apoptosis in Microvascular Endothelial Cell
h_hcmvPathway - Human Cytomegalovirus and Map Kinase Pathways
h_mapkPathway - MAPKinase Signaling Pathway
h_pyk2Pathway - Links between Pyk2 and Map Kinases
h_stressPathway - TNF/Stress Related Signaling

Reactome (by CSHL, EBI, and GO)

Protein Q16539 (Reactome details) participates in the following event(s):

R-HSA-448957 Interaction of p38 MAPK with JLP
R-HSA-1247960 Activation of p38 MAPK
R-HSA-428961 Phosphorylation of cPLA2 by MAPK p38 alpha
R-HSA-448955 Phosphorylation of MEF2 proteins by p38
R-HSA-6800434 Exocytosis of ficolin-rich granule lumen proteins
R-HSA-6798748 Exocytosis of secretory granule lumen proteins
R-HSA-450257 Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3
R-HSA-450333 Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3
R-HSA-3238999 Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK5
R-HSA-450222 Active p38 MAPK phosphorylates MAPKAPK2 or 3
R-HSA-3239019 Active p38 MAPK phosphorylates MAPKAPK5
R-HSA-198669 p38MAPK phosphorylates MSK1
R-HSA-448948 Phosphorylation of E proteins by p38 MAPK
R-HSA-1592233 p38 MAPK phosphorylates PPARGC1A
R-HSA-187688 p38 MAPK phosphorylates MAPKAPK2, MAPKAPK3
R-HSA-451152 MAP kinase p38 phosphorylates KSRP
R-HSA-3239014 MAPKAPK5 phosphorylates TP53
R-HSA-3229102 p-MAPKAPK3 phosphorylates BMI1
R-HSA-168053 Phosphorylated MAPKs phosphorylate ATF-2
R-HSA-418592 ADP signalling through P2Y purinoceptor 1
R-HSA-432142 Platelet sensitization by LDL
R-HSA-375170 CDO in myogenesis
R-HSA-168638 NOD1/2 Signaling Pathway
R-HSA-392518 Signal amplification
R-HSA-418346 Platelet homeostasis
R-HSA-6798695 Neutrophil degranulation
R-HSA-171007 p38MAPK events
R-HSA-376172 DSCAM interactions
R-HSA-4420097 VEGFA-VEGFR2 Pathway
R-HSA-525793 Myogenesis
R-HSA-168643 Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
R-HSA-76002 Platelet activation, signaling and aggregation
R-HSA-109582 Hemostasis
R-HSA-450302 activated TAK1 mediates p38 MAPK activation
R-HSA-2559580 Oxidative Stress Induced Senescence
R-HSA-198753 ERK/MAPK targets
R-HSA-2151209 Activation of PPARGC1A (PGC-1alpha) by phosphorylation
R-HSA-168249 Innate Immune System
R-HSA-167044 Signalling to RAS
R-HSA-373752 Netrin-1 signaling
R-HSA-194138 Signaling by VEGF
R-HSA-1266738 Developmental Biology
R-HSA-450604 KSRP (KHSRP) binds and destabilizes mRNA
R-HSA-450294 MAP kinase activation
R-HSA-2559583 Cellular Senescence
R-HSA-6804756 Regulation of TP53 Activity through Phosphorylation
R-HSA-450341 Activation of the AP-1 family of transcription factors
R-HSA-198725 Nuclear Events (kinase and transcription factor activation)
R-HSA-450282 MAPK targets/ Nuclear events mediated by MAP kinases
R-HSA-1592230 Mitochondrial biogenesis
R-HSA-168256 Immune System
R-HSA-187687 Signalling to ERKs
R-HSA-422475 Axon guidance
R-HSA-9006934 Signaling by Receptor Tyrosine Kinases
R-HSA-450531 Regulation of mRNA stability by proteins that bind AU-rich elements
R-HSA-166058 MyD88:Mal cascade initiated on plasma membrane
R-HSA-168164 Toll Like Receptor 3 (TLR3) Cascade
R-HSA-448424 Interleukin-17 signaling
R-HSA-937061 TRIF(TICAM1)-mediated TLR4 signaling
R-HSA-975138 TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
R-HSA-975871 MyD88 cascade initiated on plasma membrane
R-HSA-2262752 Cellular responses to stress
R-HSA-5633007 Regulation of TP53 Activity
R-HSA-187037 Signaling by NTRK1 (TRKA)
R-HSA-1852241 Organelle biogenesis and maintenance
R-HSA-162582 Signal Transduction
R-HSA-8953854 Metabolism of RNA
R-HSA-166016 Toll Like Receptor 4 (TLR4) Cascade
R-HSA-168179 Toll Like Receptor TLR1:TLR2 Cascade
R-HSA-168188 Toll Like Receptor TLR6:TLR2 Cascade
R-HSA-168898 Toll-Like Receptors Cascades
R-HSA-449147 Signaling by Interleukins
R-HSA-166166 MyD88-independent TLR4 cascade
R-HSA-975155 MyD88 dependent cascade initiated on endosome
R-HSA-168142 Toll Like Receptor 10 (TLR10) Cascade
R-HSA-168176 Toll Like Receptor 5 (TLR5) Cascade
R-HSA-8953897 Cellular responses to external stimuli
R-HSA-3700989 Transcriptional Regulation by TP53
R-HSA-166520 Signaling by NTRKs
R-HSA-181438 Toll Like Receptor 2 (TLR2) Cascade
R-HSA-1280215 Cytokine Signaling in Immune system
R-HSA-168138 Toll Like Receptor 9 (TLR9) Cascade
R-HSA-168181 Toll Like Receptor 7/8 (TLR7/8) Cascade
R-HSA-212436 Generic Transcription Pathway
R-HSA-73857 RNA Polymerase II Transcription
R-HSA-74160 Gene expression (Transcription)

-  Other Names for This Gene
  Alternate Gene Symbols: A6ZJ92, A8K6P4, B0LPH0, CSBP, CSBP1, CSBP2, CSPB1, ENST00000229795.1, ENST00000229795.2, ENST00000229795.3, ENST00000229795.4, ENST00000229795.5, ENST00000229795.6, ENST00000229795.7, MK14_HUMAN, MXI2, NM_001315, O60776, Q13083, Q14084, Q16539, Q8TDX0, SAPK2A, uc003olp.1, uc003olp.2, uc003olp.3, uc003olp.4, uc003olp.5
UCSC ID: ENST00000229795.8
RefSeq Accession: NM_001315
Protein: Q16539 (aka MK14_HUMAN)

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.